PeerView(@PeerView) 's Twitter Profileg
PeerView

@PeerView

Improving the knowledge, skills, and strategies that support clinical performance and patient outcomes through the provision of live and on-demand CE

ID:45729664

linkhttps://ww2.peerview.com calendar_today09-06-2009 01:33:18

17,8K Tweets

4,9K Followers

4,9K Following

PeerView(@PeerView) 's Twitter Profile Photo

Understand how to build the essential infrastructure for an outpatient therapy program. Watch the expert panel discussion today! With Drs Olalekan Oluwole, MBBS, MD (@olaoluwole4), Veronika Bachanova, MD, PhD, and David L. Porter, MD. bit.ly/3TevV1O

account_circle
PeerView(@PeerView) 's Twitter Profile Photo

Learn how experts are striving to cancel the threat of in post-HCT patients in this recording from the 2024 Tandem Meetings. bit.ly/49Nfwr2

account_circle
PeerView(@PeerView) 's Twitter Profile Photo

Are you aware of the latest in adjuvant & neoadjuvant treatment plans featuring PD-1 monotherapy or immune-based combinations for the treatment of resectable ? Watch oncology experts present the latest evidence at : bit.ly/40YIn81

account_circle
PeerView(@PeerView) 's Twitter Profile Photo

Join Jessica Donington, MD (donington) & Jonathan D. Spicer, MD, PhD, FRCSC (@DoctorJSpicer), for a virtual symposium on the latest advances with immunotherapies in resectable ! May 7 at 7:00 PM EDT from : bit.ly/TorNSCLC24T

account_circle
PeerView(@PeerView) 's Twitter Profile Photo

Improve team-based approaches to developing individualized care plans inclusive of the latest systemic treatments for while minimizing toxicities. Check out this activity to learn more! bit.ly/49vDoi0 Laura Dominici MD Jane Lowe Meisel, MD

account_circle
PeerView(@PeerView) 's Twitter Profile Photo

Drs. Krina Patel and Hans Lee present the current data for 'off-the-shelf' treatment options in multiple and discuss how they may be used in earlier lines of tx in our newest CME/NCPD video activity: bit.ly/49Lzy5c

account_circle
Bladder Cancer Advocacy Network(@BladderCancerUS) 's Twitter Profile Photo

Remember to join us on May 3 at 8:00 AM CDT for our in-person & virtual symposium with PeerView, and to tweet your questions in advance! Learn about mitigating & managing AEs associated with innovative treatments bit.ly/Bladder2024T

account_circle
PeerView(@PeerView) 's Twitter Profile Photo

See the latest evidence supporting treatments in metastatic, stage III unresectable & stage I-III resectable in this new video from featuring experts Drs. Patel (Sandip Patel MD), Cascone & Heymach: bit.ly/48ImRrc

account_circle
PeerView(@PeerView) 's Twitter Profile Photo

Join experts Drs. Fizazi, Chi, Pedro C Barata, MD MSc FACP, & Alicia Morgans, MD, MPH for a night of friendly competition, and get insight on developing evidence-based, guideline-recommended treatment plans. 6/1 at 6:30 PM CDT with @ZEROcancer: bit.ly/2024ProstateT

account_circle
PeerView(@PeerView) 's Twitter Profile Photo

Explore the potential of finite therapy in with the newest data on 2nd-gen BTKi/BCL2i time-limited combinations in this activity recorded at , featuring Prof. Dr. med. Stephan Stilgenbauer, Matthew Davids, MD, MMSc, Lydia Scarfò bit.ly/46m5EBS

account_circle
PeerView(@PeerView) 's Twitter Profile Photo

Get expert insight on the latest efficacy & safety data for approved & emerging tx for pts with or in a video featuring Drs. Kathleen Moore, Floor Backes & Bhavana Pothuri. Produced with National Ovarian Cancer Coalition & FdtnForWomensCancer: bit.ly/48S24kQ

account_circle
PeerView(@PeerView) 's Twitter Profile Photo

Register to join experts amit bar-or, MD, FRCPC, and Jiwon Oh, MD, PhD, FRCPC, on May 31 at 6:30 AM CDT during and better understand the current and future roles of novel biomarkers in ( ) treatment! bit.ly/2024MSL

account_circle
PeerView(@PeerView) 's Twitter Profile Photo

Refine your best practices for multidisciplinary collaboration & shared decision-making when incorporating immunotherapies into treatment plans for patients with resectable . May 7 at 7:00 PM EDT with donington & Jonathan Spicer MD PhD: bit.ly/TorNSCLC24T

account_circle
PeerView(@PeerView) 's Twitter Profile Photo

Thank you to our new followers! We appreciate YOU 🫵! Stay up-to-date with the latest in ‼️ Check out peerview.com for all our latest activities. 🩺

account_circle
PeerView(@PeerView) 's Twitter Profile Photo

Receive essential updates on the latest evidence supporting neoadjuvant, adjuvant, and for resectable . May 7 at 7:00 PM EDT. Featuring experts donington & Jonathan Spicer MD PhD! bit.ly/TorNSCLC24T

account_circle
Bladder Cancer Advocacy Network(@BladderCancerUS) 's Twitter Profile Photo

event at : Learn about strategies for innovating therapies in patients with early-stage to metastatic disease in San Antonio or online 5/3 at 8:00 AM CDT. Produced with our partner PeerView. bit.ly/Bladder2024T Ashish M. Kamat, MD, MBBS

account_circle
PeerView(@PeerView) 's Twitter Profile Photo

Unlocking the Power of Modern Therapeutic Regimens for : Register now to see Drs. Fizazi, Chi, Pedro C Barata, MD MSc FACP, & Alicia Morgans, MD, MPH compete to answer questions about the treatment landscape. 6/1 at 6:30 PM CDT with @ZEROcancer: bit.ly/2024ProstateT

account_circle
PeerView(@PeerView) 's Twitter Profile Photo

Drs. Jessica Donington (donington) & Jonathan Spicer (@doctorjspicer) want to hear about your patient with . Submit details here bit.ly/TSaCase and join the discussion on at this Saturday at 12 PM EDT!

account_circle